Clinical Trial Update: A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating monthly Mircera given subcutaneously or intravenously in dialysis patients with chronic renal anemia; the study is completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED | Results posted: 2015-12-03